Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice

Neuropsychopharmacology

Volumn 34, Issue 4, 2009, Pages 887-898

  Chefer, V I ^a   Shippenberg, T S ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Delta opioid receptor; Morphine; Reward; Sensitization; Tolerance

Indexed keywords

DELTA OPIATE RECEPTOR; MORPHINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE DELETION; KNOCKOUT MOUSE; LOCOMOTION; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REWARD; SENSITIZATION;

ANIMALS; CONDITIONING (PSYCHOLOGY); DRUG TOLERANCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; MOTOR ACTIVITY; NALTREXONE; NARCOTIC ANTAGONISTS; RECEPTORS, OPIOID, DELTA; REWARD; SPATIAL BEHAVIOR;

EID: 59949086692     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2008.128     Document Type: Article

References (57)

1. Abdelhamid EE, Sultana M, Portoghese PS, Takemori AE (1991). Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol Exp Ther 258: 299-303.
2. Bailey CP, Connor M (2005). Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 5: 60-68.
3. Cahill C M, Morinville A, Lee M C, Vincent J P, Collier B, Beaudet A (2001). Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J Neurosci 21: 7598-7607.
4. Carr GD, Fibiger HC, Phillips AG (1989). Conditioned place preference as a measure of drug reward. In: Liebman JM, Cooper SJ (eds). Neuropharmacological Basis of Reward. Oxford Science Publications, Oxford, New York. pp 264-319.
5. Clarke S, Czyzyk T, Ansonoff M, Nitsche JF, Hsu MS, Nilsson L et al (2002). Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice. Eur J Neurosci 16: 1705-1712.
6. Cohen ML, Shuman RT, Osborne JJ, Gesellchen PD (1986). Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217. J Pharmacol Exp Ther 238: 769-772.
7. Contet C, Filliol D, Matifas A, Kieffer BL (2007). Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity. Neuropharmacology 54: 475-486.
8. Corbett AD, Henderson G, McKnight AT, Paterson SJ (2006). 75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharmacol 147(Suppl 1): S153-S162.
9. Cunningham CL, Niehus DR, Malott DH, Prather LK (1992). Genetic differences in the rewarding and activating effects of morphine and ethanol. Psychopharmacology (Berl) 107: 385-393.
10. Cunningham CL, Henderson CM, Bormann NM (1998). Extinction of ethanol-induced conditioned place preference and conditioned place aversion: effects of naloxone. Psychopharmacology (Berl) 139: 32-70.
11. Cunningham CL, Ferree NK, Howard MA (2003). Apparatus bias and place conditioning with ethanol in mice. Psychopharmacology (Berl) 170: 409-422.
12. Cunningham CL, Gremel CM, Groblewski PA (2006). Drug-induced conditioned place preference and aversion in mice. Nat Protoc 1: 1662-1670.
13. Daniels DJ, Lenard NR, Etienne CL, Law PY, Roerig SC, Portoghese PS (2005). Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. Proc Natl Acad Sci USA 102: 19208-19213.
14. Di Chiara G, Bassareo V (2007). Reward system and addiction: what dopamine does and doesn't do. Curr Opin Pharmacol 7: 69-76.
15. Eitan S, Bryant CD, Saliminejad N, Yang YC, Vojdani E, Keith Jr D et al (2003). Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. J Neurosci 23: 8360-8369.
16. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F et al (2000). Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25: 195-200.
17. Fundytus ME, Schiller PW, Shapiro M, Weltrowska G, Coderre TJ (1995). Attenuation of morphine tolerance and dependence with the highly selective delta-opioid receptor antagonist TIPP[psi]. Eur J Pharmacol 286: 105-108.
18. Gibaldi M, Perier D (1975). The trapezoid rule. In: Gibaldi M, Perier D (eds). Pharmacokinetics. Marcel Dekker: New York. pp 293-296.
19. Goody RJ, Oakley SM, Filliol D, Kieffer BL, Kitchen I (2002). Quantitative autoradiographic mapping of opioid receptors in the brain of delta-opioid receptor gene knockout mice. Brain Res 945: 9-19.
20. Gupta A, Decaillot FM, Devi LA (2006). Targeting opioid receptor heterodimers: strategies for screening and drug development. AAPS J 8: E153-E159.
21. Heidbreder CA, Goldberg SR, Shippenberg TS (1993). The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res 616: 335-338.
22. Heidbreder CA, Shippenberg TS (1994). U-69593 prevents cocaine sensitization by normalizing basal accumbens dopamine. Neuroreport 5: 1797-1800.
23. Heidbreder C, Shoaib M, Shippenberg TS (1996). Differential role of delta-opioid receptors in the development and expression of behavioral sensitization to cocaine. Eur J Pharmacol 298: 207-216.
24. Hyman SE (2005). Addiction: a disease of learning and memory. Am J Psychiatry 162: 1414-1422.
25. Jordan BA, Devi LA (1999). G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399: 697-700.
26. Kalivas PW (1992). Neural substrate of sensitization to psychostimulants. Clin Neuropharmacol 15(Suppl 1 Part A): 648-649A.
27. Kornetsky C (2004). Brain-stimulation reward, morphine-induced oral stereotypy, and sensitization: implications for abuse. Neurosci Biobehav Rev 27: 777-786.
28. Law PY, Erickson-Herbrandson LJ, Zha QQ, Solberg J, Chu J, Sarre A et al (2005). Heterodimerization of mu- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions. J Biol Chem 280: 11152-11164.
29. Lenard NR, Daniels DJ, Portoghese PS, Roerig SC (2007). Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores. Eur J Pharmacol 566: 75-82.
30. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I et al (1996). Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the muopioid-receptor gene. Nature 383: 819-823.
31. Miyamoto Y, Portoghese PS, Takemori AE (1993). Involvement of delta 2 opioid receptors in acute dependence on morphine in mice. J Pharmacol Exp Ther 265: 1325-1327.
32. Morinville A, Cahill CM, Esdaile MJ, Aibak H, Collier B, Kieffer BL et al (2003). Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. J Neurosci 23: 4888-4898.
33. Morinville A, Cahill CM, Kieffer B, Collier B, Beaudet A (2004). Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain. Pain 109: 266-273.
34. Narita M, Suzuki T, Funada M, Misawa M, Nagase H (1993). Involvement of delta-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice. Psychopharmacology (Berl) 111: 423-426.
35. Nieto MM, Guen SL, Kieffer BL, Roques BP, Noble F (2005). Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors. Neuroscience 135: 305-313.
36. Nitsche JF, Schuller AG, King MA, Zengh M, Pasternak GW, Pintar JE (2002). Genetic dissociation of opiate tolerance and physical dependence in delta-opioid receptor-1 and preproenkephalin knock-out mice. J Neurosci 22: 10906-10913.
37. Portoghese PS, Sultana M, Takemori AE (1988). Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur J Pharmacol 146: 185-186.
38. Portoghese PS, Sultana M, Nelson WL, Klein P, Takemori AE (1992). Delta opioid antagonist activity and binding studies of regioisomeric isothiocyanate derivatives of naltrindole: evidence for delta receptor subtypes. J Med Chem 35: 4086-4091.
39. Roberts AJ, Gold LH, Polis I, McDonald JS, Filliol D, Kieffer BL et al (2001). Increased ethanol self-administration in delta-opioid receptor knockout mice. Alcohol Clin Exp Res 25: 1249-1256.
40. Robinson TE, Berridge KC (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18: 247-291.
41. Robinson TE, Berridge KC (2000). The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95(Suppl 2): S91-S117.
42. Rozenfeld R, Abul-Husn NS, Gomez I, Devi LA (2007). An emerging role for the delta opioid receptor in the regulation of mu opioid receptor function. ScientificWorldJournal 7: 64-73.
43. Schenk S, Ellison F, Hunt T, Amit Z (1985). An examination of heroin conditioning in preferred and nonpreferred environments and in differentially housed mature and immature rats. Pharmacol Biochem Behav 22: 215-220.
44. Schenk S, Partridge B, Shippenberg TS (2001). Effects of the kappa-opioid receptor agonist, U69593, on the development of sensitization and on the maintenance of cocaine self-administration. Neuropsychopharmacology 24: 441-450.
45. Schiller PW, Fundytus ME, Merovitz L, Weltrowska G, Nguyen TM, Lemieux C et al (1999). The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats. J Med Chem 42: 3520-3526.
46. Shippenberg TS, Bals-Kubik R, Herz A (1987). Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes. Brain Res 436: 234-239.
47. Simonin F, Slowe S, Becker JA, Matthes HW, Filliol D, Chluba J et al (2001). Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice. Eur J Pharmacol 414: 189-195.
48. Sora I, Takahashi N, Funada M, Ujike H, Revay RS, Donovan DM et al (1997). Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci USA 94: 1544-1549.
49. Spanagel R, Shippenberg TS (1993). Modulation of morphine-induced sensitization by endogenous kappa opioid systems in the rat. Neurosci Lett 153: 232-236.
50. Stewart PE, Hammond DL (1993). Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]Deltorphin. J Pharmacol Exp Ther 266: 820-828.
51. Suzuki T, Yoshiike M, Mizoguchi H, Kamei J, Misawa M, Nagase H (1994). Blockade of delta-opioid receptors prevents morphine-induced place preference in mice. Jpn J Pharmacol 66: 131-137.
52. Swerdlow NR, Gilbert D, Koob GF (1989). Conditioned drug effects on spatial preference: critical evaluation. In: Boulton AA, Baker GB, Greenshaw AJ (eds). Psychopharmacology (Neuromethods Vol 13). Humana Press: Clifton. pp 399-446.
53. Timar J, Gyarmati Z, Furst Z (2005). The development of tolerance to locomotor effects of morphine and the effect of various opioid receptor antagonists in rats chronically treated with morphine. Brain Res Bull 64: 417-424.
54. Vanderschuren LJ, Everitt BJ (2005). Behavioral and neural mechanisms of compulsive drug seeking. Eur J Pharmacol 526: 77-88.
55. Wells JL, Bartlett JL, Ananthan S, Bilsky EJ (2001). In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence. J Pharmacol Exp Ther 297: 597-605.
56. Zernig G, Ahmed SH, Cardinal RN, Morgan D, Acquas E, Foltin RW et al (2007). Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology 80: 65-119.
57. Zhu Y, King MA, Schuller AG, Nitsche JF, Reidl M, Elde RP et al (1999). Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron 24: 243-252.